PL3189844T3 - Pluripotencjalna komórka macierzysta do leczenia cukrzycowego owrzodzenia skóry - Google Patents

Pluripotencjalna komórka macierzysta do leczenia cukrzycowego owrzodzenia skóry

Info

Publication number
PL3189844T3
PL3189844T3 PL15838432T PL15838432T PL3189844T3 PL 3189844 T3 PL3189844 T3 PL 3189844T3 PL 15838432 T PL15838432 T PL 15838432T PL 15838432 T PL15838432 T PL 15838432T PL 3189844 T3 PL3189844 T3 PL 3189844T3
Authority
PL
Poland
Prior art keywords
stem cell
pluripotent stem
skin ulcer
treating diabetic
diabetic skin
Prior art date
Application number
PL15838432T
Other languages
English (en)
Inventor
Kotaro Yoshimura
Kahori KINOSHITA
Mari Dezawa
Original Assignee
The University Of Tokyo
Tohoku University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Tokyo, Tohoku University filed Critical The University Of Tokyo
Publication of PL3189844T3 publication Critical patent/PL3189844T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL15838432T 2014-09-05 2015-06-19 Pluripotencjalna komórka macierzysta do leczenia cukrzycowego owrzodzenia skóry PL3189844T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014181463A JP6452107B2 (ja) 2014-09-05 2014-09-05 糖尿病性皮膚潰瘍治療のための多能性幹細胞
EP15838432.1A EP3189844B1 (en) 2014-09-05 2015-06-19 Pluripotent stem cell for treating diabetic skin ulcer
PCT/JP2015/067789 WO2016035419A1 (ja) 2014-09-05 2015-06-19 糖尿病性皮膚潰瘍治療のための多能性幹細胞

Publications (1)

Publication Number Publication Date
PL3189844T3 true PL3189844T3 (pl) 2021-06-28

Family

ID=55439490

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15838432T PL3189844T3 (pl) 2014-09-05 2015-06-19 Pluripotencjalna komórka macierzysta do leczenia cukrzycowego owrzodzenia skóry

Country Status (14)

Country Link
US (2) US20170258844A1 (pl)
EP (1) EP3189844B1 (pl)
JP (1) JP6452107B2 (pl)
KR (2) KR20180104196A (pl)
CN (1) CN107073041A (pl)
AU (1) AU2015310286B2 (pl)
CA (1) CA2959957C (pl)
DK (1) DK3189844T3 (pl)
ES (1) ES2846795T3 (pl)
HU (1) HUE052584T2 (pl)
PL (1) PL3189844T3 (pl)
PT (1) PT3189844T (pl)
SG (1) SG11201701788YA (pl)
WO (1) WO2016035419A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6452107B2 (ja) 2014-09-05 2019-01-16 国立大学法人 東京大学 糖尿病性皮膚潰瘍治療のための多能性幹細胞
ES2882702T3 (es) * 2016-07-29 2021-12-02 Univ Tohoku Células "Muse" como agente profiláctico o terapéutico para el aneurisma
JPWO2018235834A1 (ja) * 2017-06-19 2020-04-16 国立大学法人北海道大学 表皮水疱症の治療剤
WO2019078262A1 (ja) * 2017-10-17 2019-04-25 国立大学法人広島大学 骨軟骨修復を誘導する多能性幹細胞
EP3773481A4 (en) * 2018-03-27 2022-01-05 Tautona Group IP Holding Company, L.L.C. TOPICAL AND TRANSDERMAL ADMINISTRATION OF AN IRON CHELATOR TO PREVENT AND TREAT CHRONIC WOUNDS
CN110585242A (zh) * 2019-10-15 2019-12-20 南通大学 多系分化持续应激细胞的应用、治疗糖尿病的药物及其制备方法
KR20210127510A (ko) 2020-04-14 2021-10-22 사회복지법인 삼성생명공익재단 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 당뇨병성 피부질환 예방 또는 치료용 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2564679C (en) 2004-03-22 2015-06-23 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
EP3418297B1 (en) 2005-12-13 2023-04-05 Kyoto University Nuclear reprogramming factor
KR20200124766A (ko) * 2006-10-02 2020-11-03 메조블라스트 인터내셔널 에스에이알엘 중간엽 줄기 세포 및 그에 대한 용도
CA2665475A1 (en) 2006-10-06 2008-05-22 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
HUE035043T2 (en) * 2006-10-30 2018-05-02 Genomix Co Ltd A pharmaceutical composition for promoting functional regeneration of damaged tissue
US20080193424A1 (en) * 2007-02-09 2008-08-14 Biomet Biologics, Inc. Treatment of tissue defects with a therapeutic composition
CN102083962B (zh) * 2008-04-30 2013-03-27 吉诺米克斯股份有限公司 生物体内功能性细胞的高效采集方法
US9399758B2 (en) * 2009-07-15 2016-07-26 Mari Dezawa SSEA3(+) pluripotent stem cell that can be isolated from body tissue
US9550975B2 (en) * 2009-07-15 2017-01-24 Mari Dezawa SSEA-3 pluripotent stem cell isolated from body tissue
JP2014133703A (ja) * 2011-03-30 2014-07-24 Clio Inc 生体組織から単離できるｓｓｅａ−３陽性の多能性幹細胞を含む他家移植用細胞治療用組成物
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof
KR20230059838A (ko) * 2011-11-30 2023-05-03 아스텔라스 인스티튜트 포 리제너러티브 메디슨 중간엽 간질 세포 및 이에 관련된 용도
US20150056170A1 (en) * 2012-03-06 2015-02-26 Sct&B Inc. Placental stem cells, methods for isolating same and use thereof
JP2015522257A (ja) * 2012-06-13 2015-08-06 ステムジェント， インコーポレイテッドＳｔｅｍｇｅｎｔ， Ｉｎｃ． 多能性幹細胞を調製する方法
WO2014027474A1 (ja) * 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞
JPWO2014133090A1 (ja) * 2013-02-28 2017-02-02 国立大学法人浜松医科大学 脳腫瘍治療のための多能性幹細胞
CA2903415C (en) * 2013-03-01 2021-04-20 Clio, Inc. Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to injury
JP6452107B2 (ja) 2014-09-05 2019-01-16 国立大学法人 東京大学 糖尿病性皮膚潰瘍治療のための多能性幹細胞

Also Published As

Publication number Publication date
KR20170055477A (ko) 2017-05-19
HUE052584T2 (hu) 2022-03-28
KR102136450B1 (ko) 2020-07-21
CA2959957A1 (en) 2016-03-10
CA2959957C (en) 2020-12-15
WO2016035419A1 (ja) 2016-03-10
SG11201701788YA (en) 2017-06-29
DK3189844T3 (da) 2021-01-18
EP3189844B1 (en) 2020-11-18
EP3189844A4 (en) 2018-05-02
AU2015310286A1 (en) 2017-03-23
AU2015310286B2 (en) 2018-11-08
JP6452107B2 (ja) 2019-01-16
PT3189844T (pt) 2021-02-05
US20190192574A1 (en) 2019-06-27
EP3189844A1 (en) 2017-07-12
ES2846795T3 (es) 2021-07-29
US11000552B2 (en) 2021-05-11
CN107073041A (zh) 2017-08-18
KR20180104196A (ko) 2018-09-19
JP2016056109A (ja) 2016-04-21
US20170258844A1 (en) 2017-09-14

Similar Documents

Publication Publication Date Title
IL251429A0 (en) A method for modulating immune cell activity caused by a chimeric antigen receptor
IL250072A0 (en) Transgenic cells for stress cell therapy
ZA201705673B (en) Methods for treating skin
SG11201801549VA (en) Pluripotent stem cell production system
IL250132A0 (en) A method to induce t-cell immunocytotherapy from stem cell potential
EP3145875A4 (en) Electrochemical treatment methods
EP3384007C0 (en) IMPROVED METHODS FOR REPROGRAMMING NON-PLURIPOTENT CELLS INTO PLURIPOTENT STEM CELLS
HK1222200A1 (zh) 製備多能幹細胞的方法
SG11201701788YA (en) Pluripotent stem cell for treating diabetic skin ulcer
HK1245132A1 (zh) 改善細胞治療的方法
HK1232296A1 (zh) 種鑒定細胞的方法
SG11201607925SA (en) Improved stem cell composition
IL257678A (en) Methods of stem cell transplantation
EP3132024C0 (en) CHEMICALLY INDUCED PLURIPOTENT STEM CELLS FOR SAFE THERAPEUTIC APPLICATIONS
EP3485927C0 (en) BLOOD SAMPLE TREATMENT USING OPEN PORE FOAM
HK1220637A1 (zh) 治療皮膚增厚的方法
IL247890A0 (en) Methods related to stem cells
SG11201703600YA (en) Method of distinguishing mesenchymal stem cells
IL247797A0 (en) A device for measuring sugar and a method for its use
HK1252554A1 (zh) 多能性幹細胞製造系統
EP3197467A4 (en) Treatment of diabetic foot ulcer using placental stem cells
HK1216260A1 (zh) 種臨床級胎盤間充質幹細胞製備方法
RS60218B1 (sr) Kompaktni reaktor za enzimsko lečenje
PL3177727T3 (pl) Sposoby odwadniania w procesach fermentacyjnych
KR101737796B9 (ko) 피더 비의존적 인간 전분화능줄기세포 배양방법